Possible mechanism for the gastro-intestinal adverse effects upon topical application of Prostaglandin F₂α analogs.

Author: CaiSuping, LiXiaohong, LiuXuyang, YanNaihong, ZhouXiaomin

Paper Details 
Original Abstract of the Article :
Prostaglandin F(2)α analogs (PGAs), including latanoprost, travoprost and bimatoprost, the first choice for the pharmaceutical treatment of glaucoma, are gaining more attention on their systemic side effects in recent years. The gastro-intestinal effects are among the most reported adverse effects u...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.mehy.2012.09.024

データ提供:米国国立医学図書館(NLM)

Prostaglandin F₂α Analogs: A Potential Source of Gastrointestinal Side Effects

Prostaglandin F(2)α analogs (PGAs), widely used to treat glaucoma, are gaining attention for their systemic side effects, particularly gastrointestinal effects. This study investigates the potential mechanisms underlying these side effects. The authors analyze a case report of a patient who developed gastrointestinal distress after topical application of PGAs, suggesting a possible link to the stimulation of smooth muscles in the gastrointestinal tract via prostanoid receptors.

PGA-induced Gastrointestinal Distress: A Complex Web of Receptor Interactions

The study proposes a mechanism for PGA-induced gastrointestinal distress, highlighting the role of prostanoid receptors in regulating smooth muscle function. The researchers suggest that the relative expression levels of FP and EP receptors might influence the severity of gastrointestinal side effects experienced by patients. This underscores the importance of understanding receptor selectivity in predicting and managing potential side effects of medications.

Navigating the Desert of Side Effects: A Personalized Approach

This study emphasizes the need for a personalized approach to managing medication side effects. It highlights the importance of considering individual variations in receptor expression and sensitivity when prescribing PGAs. The researchers suggest that careful monitoring and individualized treatment plans could help minimize the risk of gastrointestinal distress in patients using these medications.

Dr.Camel's Conclusion

This study, like a caravan encountering a sandstorm in the desert of drug side effects, explores the complex interplay between medications and receptor interactions. The findings highlight the importance of individualizing treatment plans to minimize potential side effects, ensuring the safe and effective use of medications to improve patient well-being.

Date :
  1. Date Completed 2013-06-05
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23098372

DOI: Digital Object Identifier

10.1016/j.mehy.2012.09.024

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.